Au Medical Center, INC

Au Medical Center, INC was paid $26.66M by Medicaid between Jan 2018 and Dec 2024, across 328 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 12% of everything it billed.

33Billing provider infoAU MEDICAL CENTER, INC
AUGUSTA, GA 30912

33aNPI1437135902assigned 12/16/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$26.66M

24GClaims659,060

24DCodes billed328

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Georgia

Rank by total paid#3 of 34

Median peer was paid$23K

This provider vs. median1,156×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	110,527	$4.05M
2019	91,285	$3.81M
2020	83,163	$3.38M
2021	110,720	$4.54M
2022	105,347	$4.34M
2023	88,513	$3.88M
2024incomplete	69,505	$2.65M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	12%	42,269	37,824	$3.23M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	10%	42,521	36,112	$2.73M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	4.6%	6,080	4,583	$1.22M
80053	Comprehensive metabolic panel	4.3%	30,868	24,720	$1.15M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.9%	15,696	14,583	$1.04M
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	3.1%	2,812	2,467	$836K
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.0%	5,315	5,094	$803K
81003		2.9%	8,620	7,341	$764K
36415	Collection of venous blood by venipuncture	2.3%	10,517	9,285	$600K
83036	Hemoglobin; glycosylated (A1C)	2.2%	6,782	6,431	$583K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.9%	7,098	2,969	$497K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.8%	4,617	4,290	$468K

316 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.7%	7,244	$448K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.6%	2,889	$428K
99284	Emergency room visit (serious)	1.6%	10,868	$422K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.2%	5,088	$324K
84156		1.2%	3,023	$323K
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.2%	6,829	$316K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.1%	315	$301K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.1%	20,976	$281K
87015		1.0%	3,800	$275K
86850		<1%	3,492	$263K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	517	$257K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,398	$252K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	3,968	$241K
80048	Basic metabolic panel (calcium, ionized)	<1%	7,378	$238K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,350	$237K
87086	Culture, bacterial; quantitative colony count, urine	<1%	7,194	$225K
94010		<1%	1,721	$220K
83880		<1%	2,413	$212K
71046	Radiologic examination, chest; 2 views	<1%	5,657	$205K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,473	$202K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	2,782	$196K
81025		<1%	5,664	$179K
99203	Doctor's office visit, new patient (routine)	<1%	3,035	$177K
82962		<1%	4,887	$158K
84439		<1%	4,239	$158K
86901		<1%	3,638	$156K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,827	$153K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,773	$147K
86900		<1%	3,642	$143K
96361	Intravenous infusion, hydration; each additional hour	<1%	2,830	$140K
84484		<1%	3,903	$135K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	2,043	$133K
82948		<1%	2,266	$131K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,499	$129K
96375	Therapeutic injection; each additional sequential IV push	<1%	4,692	$124K
85610		<1%	7,770	$123K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,746	$116K
83540		<1%	1,545	$115K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	30,227	$114K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,651	$112K
82565		<1%	453	$112K
76770		<1%	1,425	$111K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,225	$110K
90686		<1%	1,527	$107K
99285	Emergency room visit (most serious)	<1%	10,803	$105K
86780		<1%	1,676	$104K
73610		<1%	1,375	$104K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,792	$102K
73630		<1%	1,563	$92K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,452	$91K
94060		<1%	659	$89K
73560		<1%	1,614	$87K
95813		<1%	325	$79K
85007		<1%	1,485	$78K
74018		<1%	1,443	$72K
73110		<1%	846	$71K
93320		<1%	750	$71K
92526		<1%	1,387	$70K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	2,241	$70K
73130		<1%	959	$69K
87070		<1%	1,357	$65K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	137	$63K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	656	$60K
85027		<1%	11,732	$59K
70450	Computed tomography, head or brain; without contrast material	<1%	1,970	$58K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	289	$57K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	10,806	$57K
80197		<1%	1,440	$56K
93975		<1%	1,038	$55K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,023	$55K
82043		<1%	886	$51K
81001		<1%	11,056	$51K
85018		<1%	3,434	$50K
88142		<1%	901	$48K
73090		<1%	740	$47K
84702		<1%	558	$47K
96367		<1%	561	$46K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	92	$43K
84443	Thyroid stimulating hormone (TSH)	<1%	7,220	$42K
80061	Lipid panel	<1%	5,084	$42K
85014		<1%	2,572	$40K
86141		<1%	4,926	$38K
73590		<1%	646	$38K
43762		<1%	307	$38K
97162		<1%	953	$36K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	631	$36K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	53	$36K
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,389	$33K
72170		<1%	956	$32K
71045	Radiologic examination, chest; single view	<1%	3,255	$32K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	291	$30K
73030		<1%	729	$30K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,326	$27K
73564		<1%	393	$26K
G0378	Hospital observation service, per hour	<1%	4,699	$26K
J7050	Infusion, normal saline solution, 250 cc	<1%	427	$26K
D0150	Comprehensive oral evaluation - new or established patient	<1%	58	$25K
43760		<1%	54	$25K
82803		<1%	2,054	$24K
31575		<1%	69	$22K
80076		<1%	496	$21K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,362	$20K
99490	Ccm add 20min	<1%	568	$20K
99215	Doctor's office visit, returning patient (complex)	<1%	532	$19K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	472	$19K
81002		<1%	173	$19K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	5,034	$18K
83615		<1%	1,370	$18K
A9270	Non-covered item or service	<1%	5,305	$17K
94664		<1%	500	$17K
73080		<1%	207	$17K
80047		<1%	1,459	$17K
86038		<1%	107	$16K
95117		<1%	281	$15K
80069		<1%	2,045	$15K
87081		<1%	529	$15K
83605		<1%	2,215	$15K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	267	$14K
95816		<1%	43	$13K
72100		<1%	300	$13K
83735		<1%	10,920	$13K
93325		<1%	1,408	$12K
96376		<1%	1,185	$12K
87077		<1%	3,328	$12K
73502		<1%	462	$12K
83550		<1%	811	$11K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	204	$11K
J2704	Injection, propofol, 10 mg	<1%	8,387	$11K
76830	Ultrasound, transvaginal	<1%	55	$10K
87631		<1%	185	$10K
42830		<1%	13	$10K
73565		<1%	629	$9K
72082		<1%	117	$9K
76818		<1%	178	$8K
82728		<1%	2,776	$8K
99204	Doctor's office visit, new patient (more involved)	<1%	224	$8K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,355	$8K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,461	$8K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,494	$7K
87186		<1%	2,182	$7K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,040	$7K
85045		<1%	3,176	$7K
77063	Screening digital breast tomosynthesis, bilateral	<1%	213	$7K
82607		<1%	2,556	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	427	$6K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	8,912	$6K
83970		<1%	960	$5K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	37	$5K
85730		<1%	4,849	$5K
83655		<1%	248	$5K
86703		<1%	966	$5K
82784		<1%	486	$4K
90472	Immunization administration, each additional vaccine (list separately)	<1%	229	$4K
90670		<1%	23	$4K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	80	$4K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	101	$4K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,496	$4K
73552		<1%	166	$4K
87641		<1%	72	$4K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	27	$3K
82330		<1%	2,184	$3K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	32	$3K
82550		<1%	777	$3K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	363	$3K
87625		<1%	28	$3K
93308		<1%	61	$3K
93296		<1%	27	$3K
92134		<1%	405	$3K
Q3014	Telehealth originating site facility fee	<1%	64	$3K
95806		<1%	18	$3K
84132		<1%	27	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	623	$3K
82785		<1%	107	$3K
0001A		<1%	125	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,807	$3K
99173		<1%	105	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	24	$3K
83690		<1%	4,336	$3K
87075		<1%	158	$3K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	28	$2K
36416		<1%	22	$2K
41899	Unlisted procedure, dentoalveolar structures	<1%	142	$2K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,821	$2K
87040		<1%	1,370	$2K
84550		<1%	581	$2K
97166		<1%	116	$2K
94760		<1%	49	$2K
99439		<1%	91	$2K
92610		<1%	15	$2K
86359		<1%	16	$2K
0002A		<1%	72	$2K
85379		<1%	401	$2K
90681		<1%	14	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	941	$2K
D1120	Dental cleaning, child	<1%	172	$2K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	56	$2K
92015	Determination of refractive state	<1%	1,033	$1K
77336		<1%	39	$1K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	162	$1K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	202	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	565	$1K
82150		<1%	218	$1K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	91	$1K
71275	Computed tomographic angiography, chest, with contrast material	<1%	43	$1K
97116		<1%	114	$1K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	79	$1K
82570		<1%	3,117	$1K
73070		<1%	14	$1K
86803		<1%	746	$1K
90656		<1%	121	$1K
73060		<1%	39	$1K
82077		<1%	698	$1K
86832		<1%	13	$972.22
87535		<1%	12	$911.60
97161		<1%	29	$815.37
80179		<1%	106	$767.63
87536		<1%	31	$751.18
80320		<1%	478	$723.99
90715		<1%	774	$703.19
94729		<1%	137	$685.90
96127		<1%	13	$666.00
83516		<1%	103	$641.27
82951		<1%	52	$627.30
82378		<1%	15	$623.57
72125	Computed tomography, cervical spine; without contrast material	<1%	225	$567.54
82525		<1%	190	$474.37
86480		<1%	56	$467.45
93017		<1%	12	$462.38
82140		<1%	122	$420.22
88342		<1%	358	$401.73
97535	Self-care/home management training, each 15 minutes	<1%	20	$383.33
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,741	$381.14
85652		<1%	3,072	$360.90
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,490	$351.35
84590		<1%	158	$326.67
92611		<1%	13	$318.92
92133		<1%	14	$306.16
C1769	Guide wire	<1%	289	$303.62
82465		<1%	281	$294.49
84100		<1%	8,113	$282.91
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	38	$259.94
17110		<1%	14	$251.00
84597		<1%	13	$208.78
84425		<1%	146	$190.02
86360		<1%	43	$161.62
0124A		<1%	63	$158.99
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	345	$128.94
83013		<1%	54	$127.37
86769		<1%	35	$115.35
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	345	$87.60
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	56	$73.10
82746		<1%	1,396	$60.03
87799		<1%	239	$55.21
87581		<1%	441	$51.25
87486		<1%	441	$51.24
86225		<1%	40	$49.14
80143		<1%	118	$45.15
86762		<1%	72	$42.44
94727		<1%	70	$38.68
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,244	$32.67
83021		<1%	26	$23.27
97802		<1%	37	$22.78
86592		<1%	443	$5.50
76820		<1%	86	$3.85
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	264	$2.00
87340		0%	868	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	45	$0.00
D7220		0%	29	$0.00
G0008	Administration of influenza virus vaccine	0%	386	$0.00
D1206	Topical application of fluoride varnish	0%	77	$0.00
84446		0%	168	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	14	$0.00
J1815	Injection, insulin, per 5 units	0%	271	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	29	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	458	$0.00
96415		0%	114	$0.00
D7140	Extraction, erupted tooth or exposed root	0%	30	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	890	$0.00
86920		0%	123	$0.00
J3490	Unclassified drugs	0%	58	$0.00
92060		0%	129	$0.00
99292		0%	14	$0.00
36430		0%	57	$0.00
86160		0%	26	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	79	$0.00
J2060	Injection, lorazepam, 2 mg	0%	34	$0.00
G0379	Direct admission of patient for hospital observation care	0%	13	$0.00
88304		0%	13	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	35	$0.00
86364		0%	45	$0.00
84134		0%	14	$0.00
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	0%	563	$0.00
84630		0%	148	$0.00
84466		0%	1,447	$0.00
0427U		0%	27	$0.00
88365		0%	53	$0.00
97803		0%	319	$0.00
36600		0%	472	$0.00
82977		0%	38	$0.00
36592		0%	172	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	32	$0.00
82248		0%	54	$0.00
D2391	Resin-based composite - one surface, posterior, primary or permanent	0%	13	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	13	$0.00
P9016	Red blood cells, leukocytes reduced, each unit	0%	38	$0.00
D2930	Prefabricated stainless steel crown - primary tooth	0%	30	$0.00
80074		0%	12	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	13	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	95	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	18	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	30	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	39	$0.00
90648		0%	15	$0.00
90662		0%	12	$0.00
0004A		0%	12	$0.00
76937		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKEEFER, KATRINA (CEO)